17 abstracts from across the Company’s portfolio and pipeline highlight new clinical and real-world data on major depressive disorder and treatment-resistant depression New post-hoc analysis of CAPLYTA® (lumateperone) Phase 3 data… Read More
Vancouver, BC and Cincinnati, OH — A newly published study in Cognitive Behaviour Therapy has found that eSense™, a digital therapy platform for women’s sexual health, is effective in treating Sexual Interest/Arousal Disorder (SIAD)… Read More
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company), a leading global medical technology company, announced a major milestone for the In Celebration of Her™ program. Since its launch in 2014,… Read More
FRANKLIN LAKES, N.J. BD (Becton, Dickinson and Company) , a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic… Read More
The Ontario Government has announced more details on the long-awaited cancer therapies pilot dubbed the Funding Accelerated for Specific Treatments (FAST) program. It promises to allow the fast-tracking of access to… Read More
